MX2013010415A - Treatment of vaginal atrophy as novel indication for myrrh. - Google Patents

Treatment of vaginal atrophy as novel indication for myrrh.

Info

Publication number
MX2013010415A
MX2013010415A MX2013010415A MX2013010415A MX2013010415A MX 2013010415 A MX2013010415 A MX 2013010415A MX 2013010415 A MX2013010415 A MX 2013010415A MX 2013010415 A MX2013010415 A MX 2013010415A MX 2013010415 A MX2013010415 A MX 2013010415A
Authority
MX
Mexico
Prior art keywords
treatment
vaginal atrophy
myrrh
vaginal
novel indication
Prior art date
Application number
MX2013010415A
Other languages
Spanish (es)
Other versions
MX352788B (en
Inventor
Eva Brandt
Original Assignee
Sonia Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11158593.1A external-priority patent/EP2500026B1/en
Priority claimed from US13/050,225 external-priority patent/US8287924B2/en
Application filed by Sonia Pharma Gmbh filed Critical Sonia Pharma Gmbh
Publication of MX2013010415A publication Critical patent/MX2013010415A/en
Publication of MX352788B publication Critical patent/MX352788B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

The invention relates to a novel medical indication of myrrh, namely the treatment of vaginal atrophy as menopausal symptom. The invention further relates to a pharmaceutical preparation in vaginal dosage form for the treatment of vaginal atrophy and a method for preparing a pharmaceutical preparation against vaginal atrophy as menopausal symptom.
MX2013010415A 2011-03-17 2012-03-15 Treatment of vaginal atrophy as novel indication for myrrh. MX352788B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11158593.1A EP2500026B1 (en) 2011-03-17 2011-03-17 Treatment of menopausal symptoms as novel indication for myrrh
US13/050,225 US8287924B2 (en) 2011-03-17 2011-03-17 Treatment of menopausal symptoms as novel indication for myrrh
PCT/EP2012/054548 WO2012123539A1 (en) 2011-03-17 2012-03-15 Treatment of vaginal atrophy as novel indication for myrrh

Publications (2)

Publication Number Publication Date
MX2013010415A true MX2013010415A (en) 2013-12-02
MX352788B MX352788B (en) 2017-12-05

Family

ID=45929506

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010415A MX352788B (en) 2011-03-17 2012-03-15 Treatment of vaginal atrophy as novel indication for myrrh.

Country Status (8)

Country Link
JP (1) JP5519879B2 (en)
KR (1) KR20130130034A (en)
AU (1) AU2012228213B2 (en)
BR (1) BR112013023092A2 (en)
CA (1) CA2829792C (en)
CO (1) CO6771460A2 (en)
MX (1) MX352788B (en)
WO (1) WO2012123539A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2967506A1 (en) 2016-01-18 2017-07-18 Nadiah Abdulkarim A. Alessa Composition for treatment and preventative of the human papilloma virus hpv infection, ulcerations and boils
WO2020006191A1 (en) * 2018-06-29 2020-01-02 The Procter & Gamble Company Vaginal care compositions
DE112020006124T5 (en) * 2019-12-15 2022-12-08 Banooye Armaghan Teb Herbal compositions and methods of administration for treating infection and inflammation of the vulvovaginal and pelvic organs

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4592912A (en) 1983-10-31 1986-06-03 Harriet Nickolaus Ache and pain relieving and preventing composition
US4719111A (en) 1985-06-14 1988-01-12 Wilson Lynn M Novel composition for treatment of decubitus ulcers
JPS63104924A (en) * 1986-10-20 1988-05-10 Kanebo Ltd Pessary
AU630561B2 (en) 1990-06-12 1992-10-29 Cathy Palou A therapeutic preparation containing myrrh for treating skin disorders
US6350784B1 (en) * 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
US5248503A (en) 1992-01-03 1993-09-28 Emanuel King Rosalba Herbal dietary supplement
US6077513A (en) 1996-05-02 2000-06-20 Massoud; Ahmed Mohamed Ali Drug for treatment of bilharziasis (Schistosomiasis)
ZA200000192B (en) * 1998-10-30 2000-08-07 Jullienne Jacques Roger Jean M Novel composition.
US6893648B2 (en) 2002-01-04 2005-05-17 Harold Mermelstein Composition and method for treatment of vaginal dryness
CN1559586A (en) * 2004-03-04 2005-01-05 健 曹 External used Chinese patent drug for trenting gynecopathy
CN1679687A (en) 2005-02-02 2005-10-12 姚素英 External-applied capsules for treating gynecopathy and preparation thereof
CN101057892B (en) * 2006-04-19 2010-11-10 河南省宛西制药股份有限公司 Medicinal composition for treating vaginal diseases and its preparation method and application
CN101849981B (en) * 2010-06-22 2011-11-23 南京中医药大学 Myrrh target area for treatment of gynecological tumor and preparation method and application thereof

Also Published As

Publication number Publication date
JP2014508158A (en) 2014-04-03
WO2012123539A1 (en) 2012-09-20
AU2012228213B2 (en) 2015-08-06
KR20130130034A (en) 2013-11-29
BR112013023092A2 (en) 2016-12-06
AU2012228213A1 (en) 2013-09-12
JP5519879B2 (en) 2014-06-11
MX352788B (en) 2017-12-05
CO6771460A2 (en) 2013-10-15
CA2829792A1 (en) 2012-09-20
CA2829792C (en) 2017-04-04

Similar Documents

Publication Publication Date Title
GB201118656D0 (en) New compounds
MX364229B (en) COMPOSITIONS and METHODS FOR TREATING CARDIOVASCULAR DISEASES.
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
MX349004B (en) New compounds.
IN2012DN02805A (en)
MX366899B (en) New compounds.
MX356728B (en) Pharmaceutical combination for use in the treatment of diabetes type 2.
MX347734B (en) S100a4 antibodies and therapeutic uses thereof.
TN2015000135A1 (en) Modified release formulations for oprozomib
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
MX349920B (en) Production of sterile active pharmaceutical ingredients.
IN2015DN02999A (en)
MX2015005111A (en) Herbal composition for the prevention and treatment of tnf-î± mediated diseases.
MX352788B (en) Treatment of vaginal atrophy as novel indication for myrrh.
IN2014DN09240A (en)
MX2014006201A (en) Imatinib solid dosage forms reconstituted just before use.
MY197454A (en) Non-enteric pharmaceutical composition comprising crofelemer
IN2012DE00826A (en)
UA64821U (en) method for medical rehabilitation of patients with chronic uncalculary cholecystitis combined with obesity
UA74882U (en) Pharmaceutical composition for treatment of sexual dysfunction
UA97054C2 (en) Method for the treatment of patients with dependence owing to application of psychoactive substances
UA65175U (en) Method of uranostaphyloplasty
UA58747U (en) method for medical rehabilitation of patients with non-alcohol steatohepatitis
UA101418C2 (en) Pharmaceutical composition, agent for prevention and treatment of metabolic syndrome and diabetic nephropathy, process for the preparation thereof
UA65038U (en) method for treatment of patients with tocomanias

Legal Events

Date Code Title Description
FG Grant or registration